Download Research Study for Advanced Hereditary Breast Cancer

BRCA1 and BRCA2 Breast Cancer
Research Study for
Advanced Hereditary
Breast Cancer
Do you or someone you know have metastatic or locally
advanced breast cancer that is BRCA-associated?
The Brocade3 study is a research study evaluating the safety and effectiveness
of an investigational, oral medication in addition to treatment with chemotherapy
for patients with metastatic or locally advanced BRCA-associated breast cancer.
Study volunteers must meet the following criteria:
• Be ages 18 or older
• Have metastatic breast cancer or locally advanced breast cancer for which local
therapy (surgery or radiation) is not appropriate
• Have a BRCA1 or BRCA2 mutation
• Not be pregnant or breastfeeding
• Must be HER2-negative
• Other criteria apply
Compensation for travel may be available.
For more information, ask your doctor about the BROCADE3 Study
or visit www.Brocade3Study.com to see if you may qualify